A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing

The CRISPR-Cas system can treat autosomal dominant diseases by nonhomologous end joining (NHEJ) gene disruption of mutant alleles. However, many single-nucleotide mutations cannot be discriminated from wild-type alleles by current CRISPR-Cas systems. Here, we functionally screened six Cas12j nucleas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yao, Qi, Tao, Liu, Jingtong, Yang, Yuan, Wang, Ziwen, Wang, Ying, Wang, Tianyi, Li, Miaomiao, Li, Mingqing, Lu, Daru, Chang, Alex Chia Yu, Yang, Li, Gao, Song, Wang, Yongming, Lan, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2023
Materias:
Biomedicine and Life Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917002/
https://www.ncbi.nlm.nih.gov/pubmed/36763662
http://dx.doi.org/10.1126/sciadv.abo6405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917002/
https://www.ncbi.nlm.nih.gov/pubmed/36763662
http://dx.doi.org/10.1126/sciadv.abo6405

Ejemplares similares